Pesticidal formulation
A pesticide composition and solvent technology, applied in the directions of pesticides, biocides, animal repellants, etc., can solve the problem of not mentioning soluble granules, etc., to reduce the risk of exposure, reduce the degree of exposure, and reduce the risk of exposure The effect of the source
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0084] Emamectin Benzoate EC Preparation
[0085] Component Trade name %w / w
[0086] Emamectin Benzoate (Technical AI) 2.40
[0087] Butylated Hydroxytoluene BHT 1.00
[0088] Paraffin oil Semtol 70 6.40
[0089] POE30 castor oil Witconol300 18.00
[0090] [0091] Polysorbate Tween80 18.00
[0091] [0092] 1-Hexanol Epal6 54.20
[0092] The emulsified composition is made by blending all ingredients together and stirring until dissolved.
[0093] Emamectin benzoate soluble granule preparation
[0094] components Product name %w / w
[0095] Emamectin Benzoate (Technical AI) 5.31
[0096] Polysiloxane Rhodorsil EP 6703 0.10
[0097] Sodium alkylnaphthalene sulfonate Sellogen DFL 1.00
[0098] Sodium N-methyl N-oleoyl taurate Adinol OT-64 7.50
[0099] Anhydrous Lactose Direct Tableting Grade 86.09
[0100] components Product name %w / w
[0101] Emamectin Benzoate (Technical AI) 1.078
[0102] Polysiloxane Rhodorsil EP 6703 0.020
[0103] Sodium alky...
Embodiment 2
[0125] components Product name %w / w
[0126] Emamectin Benzoate (Technical AI) 5.4
[0127] Fumed silica Cab-O-Sil M5 0.75
[0128] Sodium N-Methyl N-Oleoyl Taurate Ceropon T77 0.75
[0129] Polysiloxane EP-6703 0.1
[0130] Anionic Surfactant Blend Witcosperse D60 3.0
[0131] Starch Sta-RX 10.0
[0132] Lactose Anhydrous Direct Tableting Grade 79.9
[0133] A dry ingredient soluble granule formulation is made by blending all powders together. 15% water was added to the dry ingredients and the resulting powder was extruded with an LCI Benchtop extruder with a 0.8 mm sieve to obtain wet granules which were then dried overnight at 54°C.
[0134] In the field trials comparing efficacy described below, the efficacy of the soluble granule formulation was statistically equal to that of the emulsified composition formulation. Both formulations were subjected to the acute eye irritation test described below and the emulsified composition was found to be particularly irrit...
Embodiment 3
[0137] Change in percent active ingredient
[0138] components (%w / w) A B C D E F
[0139] Emamectin benzoate 1 2 5 10 25
[0140] 50
[0141] Polysiloxane 0.1 0.1 0.1 0.1 0.1 0.1
[0142] Sodium N-methyl-N-oleoyl taurate 7.5 7.5 7.5 7.5 7.5 7.5
[0143] Sodium alkylnaphthalene sulfonate 1.0 1.0 1.0 1.0 1.0 1.0
[0144] Anhydrous lactose 90.4 89.4 86.4 81.4 66.4 41.4
[0145] As demonstrated in this example, the amount of active ingredient (emamectin benzoate) need not be controlled to 5%, but can be greater than 5%. Various indicated Compositions. When the granules were dispersed in water, a clear solution containing emamectin benzoate was obtained.
[0146] Example 4
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com